MDS Prognosis - Understanding IPSS and IPSS-R Scores 2018

IPSS-R vs IPSS-M for MDS

(R-IPSS) Revised International Prognostic Scoring System for MDS

Relevance of the IPSS-R during SCT in patients with MDS in the molecular classification era

Revised IPSS Score for MDS prognosis

Relevance of IPSS-R for risk stratification in patients with MDS who undergo SCT

Use of Molecular Genetic Testing in MDS and MPN

International Prostate Symptom Score (IPSS) in 2 minutes

#280 Development and Pilot Testing of a Simplified Version of the International Prostate Symptom...

Evaluating IPSS-R and IPSS-M in patients with HR-MDS enrolled in STIMULUS-MDS1 and STIMULUS-MDS2

Elsa Bernard: IPSS-M in MDS | #10 | Trainee Pearls

Real-world validation of the value of the IPSS-M for prognostication in patients with MDS

6-Molecular prognostic scoring (IPSS-M) – How does it improve patient management?

Validation of the IPSS-M risk stratification system in MDS

What factors should we consider for intermediate- and high-risk patients beyond the IPSS-R score?

【BCF2023】骨髄異形成症候群（MDS）

What is the difference between the IPSS and the IPSS-R?

Myelofibrosis Prognostic Scoring Systems: IPSS, DIPSS, DIPSS-Plus, MISPS, and GIPSS

Updates in MDS diagnosis and prognosis with the IPSS-M: personalized medicine in 2023

My approach to MDS management